Welcome to our dedicated page for ORASURE TECHNOLOGIES SEC filings (Ticker: OSUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
OraSure Technologies Inc. filings document the regulatory record of a Nasdaq-listed diagnostics and sample management company. Its Form 8-K reports cover quarterly and annual operating results, Regulation FD presentations, business developments, board changes, and material agreements tied to shareholder and governance matters.
OraSure's proxy materials disclose director elections, executive compensation, board committee structure, shareholder voting matters and governance proposals, including matters related to board classification. The filings also identify the company's common stock listing, capital structure, risk and governance disclosures, and formal records for cooperation agreements, director appointments, resignations and investor communications.
OraSure Technologies (OSUR) announced Board changes. On October 28, 2025, Mara G. Aspinall resigned as director and chair of the Board, effective immediately, and the company stated her resignation was not due to any dispute or disagreement. The Board appointed John P. Kenny, a current director, as the new chair.
The Board also appointed Steven Boyd as a Class II director effective October 28, 2025, with a term through the 2026 Annual Meeting. He was deemed independent under Nasdaq rules and Rule 10A-3 and will serve on the Audit and Nominating & Corporate Governance Committees. Under the director compensation policy, he will receive time-vested restricted shares valued at $100,000 that vest in two years.
Dimensional Fund Advisors LP reported ownership of 3,636,260 shares of OraSure Technologies Inc common stock, representing 5.0% of the outstanding class. Dimensional states it has sole voting power for 3,560,315 shares and sole dispositive power for 3,636,260 shares, while disclaiming beneficial ownership because the shares are held by various funds it advises.
The filing is a Schedule 13G/A indicating a passive, investment-adviser position rather than an activist stake. The report explains the holdings arise from Dimensional’s advisory roles to registered investment companies, commingled funds, group trusts and separate accounts and notes no group affiliation or parent-subsidiary acquisition activity is claimed.
OraSure Technologies (OSUR) director John P. Kenny received 6,118 restricted shares on 09/24/2025 under the company's Stock Award Plan in lieu of cash fees. The shares were granted at an indicated price of $3.269 and vest immediately, increasing Mr. Kenny's beneficial ownership to 153,322 shares. The Form 4 was signed by an attorney-in-fact on 09/26/2025. The filing records this as a non-derivative acquisition and specifies the grant was made under the company plan as compensation for director fees.
Altai Capital Management and related parties disclosed a 5.13% stake in OraSure Technologies (OSUR), reporting ownership of 3,748,836 shares. The position is held for accounts managed by Altai, acquired with about $11,461,291 of working capital. The filing states the stake was purchased for investment purposes and that Altai may engage with OraSure management, the board, shareholders or other parties about matters including strategy, governance and capital structure, but currently has no contracts or formal plans to effect specific changes. All shares are reported as shared voting and dispositive power; no sole voting power is claimed.
Earnest Partners, LLC filed Amendment No. 1 to a Schedule 13G reporting its holdings of OraSure Technologies, Inc. (OSUR) common stock. The amendment states Earnest Partners beneficially owned 795 shares, representing 0.0% of the class, and that it ceased to own more than 5% of the issuer as of December 31, 2022. The filing notes it was submitted late due to an inadvertent oversight and affirms the shares were not held with any control intent. The amendment is signed by the firm’s Chief Compliance Officer on 09/03/2025.
OraSure Technologies Chief Financial Officer Kenneth J. McGrath reported a Form 4 disclosing a tax-withholding disposition tied to the vesting of restricted stock. On 08/08/2025 the filing shows 12,524 shares were withheld to satisfy tax obligations at a reported price of $2.78 per share. After the withholding he beneficially owned 448,463 shares directly.
The filing is a routine Section 16 disclosure related to compensation vesting rather than an open-market sale. The explanation on the form explicitly states the shares were withheld to pay the tax liability associated with vested restricted shares, indicating this transaction reflects tax withholding on compensation.
OraSure Technologies (OSUR) – Form 4 filing, 07/31/2025: Director Robert W. McMahon satisfied tax withholding on recently vested restricted stock by having 7,317 common shares withheld by the company at an implied price of $3.205 per share (Transaction Code F). Following the transaction, McMahon continues to hold 99,919 shares directly. No derivative securities were reported.
Code F denotes a non-open-market disposition strictly for tax obligations; therefore, it does not represent an active sale decision and has minimal signalling value. The remaining stake indicates continued alignment with shareholders. No other transactions, options, or changes in beneficial ownership were disclosed.